Rchr
J-GLOBAL ID:202001006909069917   Update date: Jun. 09, 2020

Kazuyoshi Kawakami

Kazuyoshi Kawakami
Research field  (1): Clinical pharmacy
Papers (40):
  • Takashi Yokokawa, Kenichi Suzuki, Takahito Sugisaki, Kazuo Kobayashi, Daigo Shouji, Hiroshi Watanabe, Kazuyoshi Kawakami, Tomomi Takiguchi, Takeshi Aoyama, Kokoro Kobayashi, Shunji Takahashi, Yoshinori Ito, Shinji Ohno, Toshihiro Hama. Impact of Primary Pegfilgrastim Prophylaxis on Relative Dose Intensity in Neoadjuvant/Adjuvant FEC-100 Chemotherapy. Anticancer research. 2020. 40. 2. 915-921
  • Takeshi Aoyama, Takashi Tsunoda, Hiroki Kato, Akane Hagino, Ryota Furutani, Kazuyuki Ito, Hidenori Yoshioka, Masashi Nakamura, Makoto Hiraide, Kazuyoshi Kawakami, Kazuo Kobayashi, Kenichi Suzuki, Takashi Ichimura, Kensei Yamaguchi, Toshihiro Hama. Comparison of cisplatin-induced nephrotoxicity when using conventional versus short hydration in gastric cancer-a retrospective study. Journal of chemotherapy (Florence, Italy). 2020. 1-7
  • Chiba T, Kambe T, Yamamoto K, Kawakami K, Taguchi K, Abe K. Vincristine increased spinal cord substance P levels in a peripheral neuropathy rat model. Drug and chemical toxicology. 2020. 1-5
  • Yuma Nonomiya, Takashi Yokokawa, Kazuyoshi Kawakami, Kazuo Kobayashi, Takeshi Aoyama, Tomomi Takiguchi, Takahito Sugisaki, Kenichi Suzuki, Mitsukuni Suenaga, Takeru Wakatsuki, Kensei Yamaguchi, Yoshikazu Sugimoto, Toshihiro Hama. Regorafenib-Induced Hand-Foot Skin Reaction Is More Severe on the Feet Than on the Hands. Oncology research. 2019. 27. 5. 551-556
  • Kazuo Kobayashi, Kazuyoshi Kawakami, Takashi Yokokawa, Takeshi Aoyama, Kenichi Suzuki, Takeru Wakatsuki, Mitsukuni Suenaga, Hitoshi Sato, Erika Sugiyama, Kensei Yamaguchi, Toshihiro Hama. Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer. Oncology. 2019. 96. 4. 200-206
more...
MISC (94):
  • 川上和宜. プロフェッショナルEYE 専門薬剤師からみた勘所 抗がん薬による副作用重篤化リスク因子を明らかにして,薬学的ケアに生かす!. 薬局. 2019. 70. 6. 1376-1383
  • 川上和宜. 抗がん薬の有害事象の評価. 薬局. 2019. 70. 4. 751-752,1083-1084
  • 川上和宜. 手足症候群の副作用マネジメント. 薬局. 2019. 70. 4. 749-750,1083
  • 川上和宜. 末梢神経障害とその支持療法. 薬局. 2019. 70. 4. 753-754,1084
  • 川上和宜. 免疫チェックポイント阻害薬使用時の注意点と副作用マネジメント. 薬局. 2019. 70. 4. 755-756,1084
more...
Lectures and oral presentations  (24):
  • Risk factors for severe neutropenia among pancreatic cancer patients receiving nab-paclitaxel and gemcitabine combination therapy
    (ASCO-GI 2020;Gastrointestinal Cancers Symposium 2020)
  • GEM+nab-PTX療法・FOLFIRINOX療法におけるCIPNに対するduloxetineの効果
    (日本臨床腫瘍薬学会学術大会講演要旨集 2019)
  • 内服自己管理薬に関するインシデント事例の解析
    (医療の質・安全学会誌 2018)
  • 医療安全管理部門に関わる薬剤師に求められる医薬品情報管理 がん専門病院に勤務する医療安全管理部門の専従薬剤師に求められる医薬品情報
    (日本医薬品情報学会総会・学術大会講演要旨集 2018)
  • がん専門病院に勤務する医療安全管理部門の専従薬剤師に求められる医薬品情報
    (日本医薬品情報学会総会・学術大会講演要旨集 2018)
more...
Education (1):
  • 1994 - 1998 Showa Pharmaceutical University Faculty of Pharmaceutical Sciences Department of Bio-Pharmacy
Work history (4):
  • 2019/05 - 現在 Japanese Foundation for Cancer Research
  • 2018/08 - 2019/04 Japanese Foundation for Cancer Research
  • 2016/05 - 2018/07 Japanese Foundation for Cancer Research
  • 2011/10 - 2016/04 Japanese Foundation for Cancer Research
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page